On November 27, 2025, the Standard Interconnection and Smooth International Trade Salon (Life and Health Special Session) was successfully held in Minhang District, Shanghai. This event was guided by China National Health Association, sponsored by Hongqiao Overseas Development Service Center, jointly sponsored by Beijing Medical Device Chamber of Commerce and Mystuff Group, and co-organized by Shanghai Panzhiyin Enterprise Management Partnership (Limited Partnership). More than 50 people from all walks of life in government, industry, academia and research attended the meeting. The meeting was chaired by Xie Tingting, director of the office of Mystuff (Suzhou) Technology Group.

Wang Guibao, Deputy Executive Secretary-General of Standardization Technical Committee of China National Health Association, Shenyang Yang, Operation Head of Hongqiao Overseas Development Service Center, and Jiang Yubiao, Chairman of Shanghai Panzhiyin Enterprise Management Partnership (Limited Partnership), respectively delivered speeches at the event. In the keynote report session, five experts shared in-depth about life and health enterprises going overseas: Zhao Hailong, senior regulatory consultant of CCIC Huatongwei Testing Technology Research Institute, interpreted the laws and policies of key areas of medical devices going overseas; Wang Tingting, the domestic counterpart contact of the Technical Committee on Medical Device Quality Management and General Requirements of the International Organization for Standardization (ISO) and deputy secretary-general of the National Technical Committee on Standardization of Medical Device Quality Management and General Requirements, analyzed the latest developments of medical device quality management standards at home and abroad; Ma Honglei, Chief Technology Officer of Mystuff (Suzhou) Technology Group, put forward his insights on the intellectual property barriers and coping strategies faced by enterprises in the process of going overseas; Qian Qiang, deputy general manager of Beijing Shangdao Green Finance Consulting Co., Ltd., discussed the implementation path of ESG for enterprises going overseas; Chen Bingdi, professor of Tongji University School of Medicine and founder and chairman of Zhihui Medical Technology (Shanghai) Co., Ltd., shared his practical experience in the standardization of CTC blood test methods. The reports of the experts have both theoretical height and practical guiding significance, and provide practical and feasible ideas for international development for participants.

The round table session was chaired by Wang Zhaozhu, general manager of Mystuff (Suzhou) Technology Group. Representatives of Zhenming (Jiangxi) Pharmaceutical Co., Ltd., Yunnan Baiyao Group Co., Ltd., Taizhou Tongweishi Eye Health Technology Co., Ltd., Shanghai Chunshen Exosome Biomedical Co., Ltd., Shanghai Jihe Shengfang Biotechnology Co., Ltd. and other enterprises held a heated discussion about "How standard interconnection can help enterprises break the barriers of going overseas", and shared their respective experiences and challenges in dealing with overseas standard differences and achieving compliance going overseas.

This salon focused on the pain points and needs of the life and health industry going overseas, and provided enterprises with systematic solutions from standard docking, compliance implementation to ESG integration, which was highly praised by the participants. As a co-organizer, Mystuff Group said that it will continue to deepen the field of "standard interconnection", and rely on professional services such as technical indicator comparison, global standard navigation, standard status tracking, technical and trade measures monitoring, mutual recognition of standard development, standard essential patents, standard compliance testing and certification, and ESG dynamic adaptation to help more life and health enterprises steadily explore the international market and achieve high-quality overseas.